期刊文献+

HPLC-MS/MS法测定人体血浆中扎托布洛芬的浓度 被引量:1

HPLC-MS/MS determination of zaltoprofen in human plasma
原文传递
导出
摘要 目的:建立灵敏、快速和选择性高的高效液相色谱串联质谱法(HPLC-MS/MS)测定人血浆中扎托布洛芬浓度。方法:采用Agilent ZORBAX Eclipse Plus-C18(150 mm×4.6 mm,5μm)色谱柱,流动相为甲醇-0.1%甲酸水溶液(90:10,v/v),地西泮为内标,以多反应监测(MRM)扫描方式进行监测,监测离子质荷比:扎托布洛芬m/z 299.2→m/z 225.2,地西泮m/z 285.1→m/z193.1,血浆样品经乙腈沉淀蛋白后取上清液进样。结果:血浆中扎托布洛芬线性范围为0.02~20.0μg.mL-1,低、中、高3个浓度日内、日间精密度均小于10%。结论:本方法灵敏度高,选择性强,分析时间短,适用于人血浆中扎托布洛芬的浓度测定。 Objective:To develop and validate a method for the determination of zaltoprofen in human plasma by HPLC-MS/MS.Methods:An Agilent ZORBAX Eclipse Plus-C18(150 mm×4.6 mm,5 μm) was adopted with the mobile phase of methanol and 0.1% formic acid(90:10,v:v).Diazepam was used as internal standard.Multiple reaction monitoring(MRM) mode was employed,and the transition of m/z was m/z 299.2→m/z 225.2 for zaltoprofen,m/z 285.1→m/z193.1 for diazapan.The plasma samples were simply pretreated by protein precipitation.Results:The calibration curves of zaltoprofen was linear in the range of 0.02-20.0 μg·mL-1.RSDs of the inter-day and intra-day precisions of low,medium and high concentrations were all less than 10%.Conclusion:The method is sensitive,specific,rapid and suitable for the determination of zaltoprofen in human plasma.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第6期941-944,949,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 扎托布洛芬 液相色谱 质谱法 血药浓度 药代动力学 人血浆 zaltoprofen liquid chromatography mass spectrometry plasma drug concentration pharmacokinetics human plasma
  • 相关文献

参考文献13

  • 1Hatori M, Kokubun S. The long - term efficacy and tolerability of the new anti - inflammatory agent zahoprofen in rheumatoid arthritis. Curr Med Res Opin,1998,14( 2 ) :79.
  • 2Tsurumi K, Kyuki K, Niwa M, et al. Pharmacological investigations of the new antiinflammatory agent 2 - [ 10,11 - dihydro - 10 - ox- odibenzo( b, f) thiepin - 2 - yl ] propionic acid. Arzneimittelfors- chung ,1986 ,36(12 ) :1796.
  • 3Pareek A, Gupta AK, Chandurkar NB,et al. Zaltoprofen, a noninferi- or alternative to diclofenac for the treatment of primary knee osteoar- thritis- a comparative evaluation of efficacy and safety in a 4 - week, multicentric, randomized, double - blind, double - dummy tri- al. Exp Opin Pharmacother ,2011,12 (7) : 1007.
  • 4Kawai S, Nishida S, Kato M, et al. Comparison of cyclooxygenase - 1 and - 2 inhibitory activities of various nonsteroidal anti - inflammato- ry drugs using human platelets and synovial cells. Eur J Pharmacol, 1998,347( 1 ) :87.
  • 5Kawai S. Cyclooxygenase selectivity and the risk of gastro - intestinal complications of various non - steroidal anti - inflammatory drugs : a clinical consideration. Inflamm Res, 1998,47 Suppl 2 : S102.
  • 6Hirate K, Uchida A, Ogawa Y, et al. Zaltoprofen, a non - steroidal anti - inflammatory drug, inhibits bradykinin - induced pain respon- ses without blocking bradykinin receptors. Neurosci Res, 2006,54 (4) :288.
  • 7Tang H, Inane A, Oshita K, et al. Zaltoprofen inhibits bradykinin - induced responses by blocking the activation of second messenger signaling cascades in rat dorsal root ganglion cells. Neuropharmacolo- gy,2005,48 (7) : 1035.
  • 8Miskai M, Makoto I, Hiroshi U. NSAID zaltoprofen possesses novel anti - nociceptive mechanism through blockage of B2 - type bradyki-nin receptor in nerve endings. Neurosci Lett ,2006,397 (3) :249.
  • 9Kohno T. Zaltoprofen inhibits bradykinin - mediated enhancement of glutamate receptor activity in substantia gelatinosa neurons. Anesth A- nal,2011,113(2) :412.
  • 10Azuma A, Kudoh S, Nakashima M,et al. A double - blind study of za- ltoprofen for the treatment of upper respiratory tract infection. Phar- macology,2010,85( 1 ) :41.

同被引文献11

  • 1许铁男.抗炎镇痛药 扎托洛芬[J].国外医药(合成药.生化药.制剂分册),1995,16(5):306-307. 被引量:6
  • 2汪涛,邓树海,徐丽洒,万发里.HPLC测定扎托洛芬片的含量及有关物质[J].中国药学杂志,2007,42(5):389-390. 被引量:2
  • 3Hatori M, Kokubun S, Curr. The Long-term Efficacy and Tolerability of the New Anti-inflammatory AgentZaltoprofen in Rheumatoid Arthritis[J]. Med Res Opin, 1995, 14 (2) : 79-87.
  • 4Sun Ok Choi, So Young Uma, Sung Hee Jung. Column- switching High-performance Liquid Chromatographic Method for the Determination of Zaltoprofen in Rat Plasma[J]. Journal of Chromatography B, 2006, 830: 301-305.
  • 5Yang HK, Kim SY, Kim Js, et al. Aplication of Column- swiching HPLC Method in Evaluation Pharmacokinetic Parameters of Zahoprofen and Its Salt[J]. Biomed Chromatogr, 2009, 23 (3) : 537-540.
  • 6Li LJ, Ma PC, Cao YP, et al. Single-dose and Multiple- dose Pharmacokinetics of Zahoprofen after Oral Administration in Healthy Chinese Volunteers[J]. Journal of BiomedicalResearch, 2012, 25 (1) : 56-62.
  • 7Heon-Woo Lee, Ji-Hyung Seo, Yong-Won Kim, et al. Determination of Zahoprofen in Human Plasma by Liquid Chromatography with Electrospray Tandem Mass Spectrometry: Application to a Pharmaeokinetic Study[J]. Rapid Commun Mass Spectrom, 2006, 20: 2675-2680.
  • 8钱映美,钟大放.人血浆中扎托布洛芬和硫普罗宁定量分析方法研究[D]//中国优秀硕士学位论文全文数据库.杭州:浙江工业大学,2011.
  • 9钱映美,詹燕,张逸凡,文爱东,钟大放.人血浆中扎托布洛芬的LC-MS/MS法测定[J].中国医药工业杂志,2011,42(8):618-621. 被引量:1
  • 10余凤玮,孙逊,张彦,刘福,龚涛,张志荣.HPLC测定扎托布洛芬缓释胶囊的含量[J].华西药学杂志,2012,27(3):330-331. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部